0001551152falseDecember 312021Q2100015511522021-01-012021-06-300001551152us-gaap:CommonStockMemberexch:XCHI2021-01-012021-06-300001551152us-gaap:CommonStockMemberexch:XNYS2021-01-012021-06-300001551152abbv:Sec1500SeniorNotesDue2023Memberexch:XNYS2021-01-012021-06-300001551152exch:XNYSabbv:Sec1.375SeniorNotesDue2024Member2021-01-012021-06-300001551152abbv:Sec1250SeniorNotesDue2024Memberexch:XNYS2021-01-012021-06-300001551152abbv:Sec0.750SeniorNotesDue2027Memberexch:XNYS2021-01-012021-06-300001551152abbv:Sec2.125SeniorNotesdue2028Memberexch:XNYS2021-01-012021-06-300001551152abbv:Sec2625SeniorNotesDue2028Memberexch:XNYS2021-01-012021-06-300001551152exch:XNYSabbv:Sec2125SeniorNotesDue2029Member2021-01-012021-06-300001551152abbv:Sec1.250SeniorNotesdue2031Memberexch:XNYS2021-01-012021-06-30xbrli:shares00015511522021-07-26iso4217:USD00015511522021-04-012021-06-3000015511522020-04-012020-06-3000015511522020-01-012020-06-30iso4217:USDxbrli:shares00015511522021-06-3000015511522020-12-310001551152us-gaap:CommonStockMember2020-03-310001551152us-gaap:TreasuryStockMember2020-03-310001551152us-gaap:AdditionalPaidInCapitalMember2020-03-310001551152us-gaap:RetainedEarningsMember2020-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001551152us-gaap:NoncontrollingInterestMember2020-03-3100015511522020-03-310001551152us-gaap:CommonStockMember2020-04-012020-06-300001551152us-gaap:TreasuryStockMember2020-04-012020-06-300001551152us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300001551152us-gaap:RetainedEarningsMember2020-04-012020-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300001551152us-gaap:NoncontrollingInterestMember2020-04-012020-06-300001551152us-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300001551152us-gaap:CommonStockMember2020-06-300001551152us-gaap:TreasuryStockMember2020-06-300001551152us-gaap:AdditionalPaidInCapitalMember2020-06-300001551152us-gaap:RetainedEarningsMember2020-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300001551152us-gaap:NoncontrollingInterestMember2020-06-3000015511522020-06-300001551152us-gaap:CommonStockMember2021-03-310001551152us-gaap:TreasuryStockMember2021-03-310001551152us-gaap:AdditionalPaidInCapitalMember2021-03-310001551152us-gaap:RetainedEarningsMember2021-03-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001551152us-gaap:NoncontrollingInterestMember2021-03-3100015511522021-03-310001551152us-gaap:CommonStockMember2021-04-012021-06-300001551152us-gaap:TreasuryStockMember2021-04-012021-06-300001551152us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001551152us-gaap:RetainedEarningsMember2021-04-012021-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001551152us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001551152us-gaap:CommonStockMember2021-06-300001551152us-gaap:TreasuryStockMember2021-06-300001551152us-gaap:AdditionalPaidInCapitalMember2021-06-300001551152us-gaap:RetainedEarningsMember2021-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001551152us-gaap:NoncontrollingInterestMember2021-06-300001551152us-gaap:CommonStockMember2019-12-310001551152us-gaap:TreasuryStockMember2019-12-310001551152us-gaap:AdditionalPaidInCapitalMember2019-12-310001551152us-gaap:RetainedEarningsMember2019-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001551152us-gaap:NoncontrollingInterestMember2019-12-3100015511522019-12-310001551152us-gaap:CommonStockMember2020-01-012020-06-300001551152us-gaap:TreasuryStockMember2020-01-012020-06-300001551152us-gaap:RetainedEarningsMember2020-01-012020-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300001551152us-gaap:NoncontrollingInterestMember2020-01-012020-06-300001551152us-gaap:CommonStockMember2020-12-310001551152us-gaap:TreasuryStockMember2020-12-310001551152us-gaap:AdditionalPaidInCapitalMember2020-12-310001551152us-gaap:RetainedEarningsMember2020-12-310001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001551152us-gaap:NoncontrollingInterestMember2020-12-310001551152us-gaap:CommonStockMember2021-01-012021-06-300001551152us-gaap:TreasuryStockMember2021-01-012021-06-300001551152us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001551152us-gaap:RetainedEarningsMember2021-01-012021-06-300001551152us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001551152us-gaap:NoncontrollingInterestMember2021-01-012021-06-300001551152abbv:AllerganplcMember2021-01-012021-06-300001551152srt:ScenarioForecastMemberus-gaap:CollaborativeArrangementMemberus-gaap:InProcessResearchAndDevelopmentMemberabbv:TeneoOneAndTNB383BMember2021-07-012021-09-300001551152srt:ScenarioForecastMemberus-gaap:CollaborativeArrangementMemberabbv:TeneoOneAndTNB383BMembersrt:MaximumMember2021-09-300001551152abbv:SolitonIncMembersrt:ScenarioForecastMember2021-08-020001551152abbv:SolitonIncMembersrt:ScenarioForecastMember2021-08-022021-08-020001551152abbv:CalicoLifeSciencesLLCMembersrt:ScenarioForecastMemberus-gaap:CollaborativeArrangementMember2021-07-012021-09-300001551152abbv:GenmabASMemberus-gaap:CollaborativeArrangementMemberus-gaap:InProcessResearchAndDevelopmentMember2020-04-012020-06-300001551152abbv:GenmabASMemberus-gaap:CollaborativeArrangementMembersrt:MaximumMember2020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2021-06-30xbrli:pure0001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2021-01-012021-06-300001551152abbv:JanssenBiotechIncMember2021-01-012021-06-300001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2021-04-012021-06-300001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2020-04-012020-06-300001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2021-01-012021-06-300001551152country:USus-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2020-01-012020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMemberus-gaap:NonUsMember2021-04-012021-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMemberus-gaap:NonUsMember2020-04-012020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMemberus-gaap:NonUsMember2021-01-012021-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMemberus-gaap:NonUsMember2020-01-012020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2021-04-012021-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2020-04-012020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2020-01-012020-06-300001551152us-gaap:CollaborativeArrangementMemberabbv:JanssenBiotechIncMember2020-12-310001551152abbv:GenentechInc.Member2021-01-012021-06-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-04-012021-06-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2020-04-012020-06-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-01-012021-06-300001551152abbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2020-01-012020-06-300001551152country:USabbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-04-012021-06-300001551152country:USabbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2020-04-012020-06-300001551152country:USabbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2021-01-012021-06-300001551152country:USabbv:GenentechInc.Memberus-gaap:CollaborativeArrangementMember2020-01-012020-06-300001551152us-gaap:DevelopedTechnologyRightsMember2021-06-300001551152us-gaap:DevelopedTechnologyRightsMember2020-12-310001551152us-gaap:LicensingAgreementsMember2021-06-300001551152us-gaap:LicensingAgreementsMember2020-12-310001551152abbv:AllerganIntegrationPlanMember2021-06-300001551152abbv:AllerganIntegrationPlanMember2021-01-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2020-04-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2021-01-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMemberus-gaap:EmployeeSeveranceMember2020-01-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMember2021-04-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMember2020-04-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMember2021-01-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:CostOfSalesMember2020-01-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-04-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-04-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-04-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-04-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2021-04-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2020-04-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2021-01-012021-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2020-01-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2021-04-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2020-04-012020-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2021-01-012021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2020-01-012020-06-300001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2020-12-310001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2020-12-310001551152abbv:AllerganIntegrationPlanMemberus-gaap:EmployeeSeveranceMember2021-06-300001551152us-gaap:OtherRestructuringMemberabbv:AllerganIntegrationPlanMember2021-06-300001551152abbv:OtherRestructuringPlansMember2021-04-012021-06-300001551152abbv:OtherRestructuringPlansMember2021-01-012021-06-300001551152abbv:OtherRestructuringPlansMember2020-04-012020-06-300001551152abbv:OtherRestructuringPlansMember2020-01-012020-06-300001551152abbv:OtherRestructuringPlansMember2020-12-310001551152abbv:OtherRestructuringPlansMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:TreasuryLockMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-09-300001551152us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-12-31iso4217:EUR0001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:OtherLiabilitiesMemberus-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-06-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMember2020-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:OtherNoncurrentAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:OtherLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:OtherLiabilitiesMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:FairValueHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:FairValueHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:OtherLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-06-300001551152us-gaap:OtherLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-12-310001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:CostOfSalesMember2021-06-300001551152us-gaap:InterestExpenseMember2021-06-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:SeniorNotesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:ForeignExchangeForwardMemberus-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:InterestExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:InterestExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:InterestExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:InterestExpenseMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-04-012021-06-300001551152us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-04-012020-06-300001551152us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-01-012021-06-300001551152us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2020-01-012020-06-300001551152us-gaap:TreasuryLockMemberus-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:TreasuryLockMemberus-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:TreasuryLockMemberus-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:TreasuryLockMemberus-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-04-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2021-04-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2020-04-012020-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2021-01-012021-06-300001551152us-gaap:InterestExpenseMemberus-gaap:FairValueHedgingMember2020-01-012020-06-300001551152us-gaap:FairValueMeasurementsRecurringMember2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-06-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-06-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-06-300001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2021-06-300001551152us-gaap:FairValueMeasurementsRecurringMember2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2020-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-12-310001551152us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel1Member2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2020-12-310001551152us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2020-12-310001551152us-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2021-06-300001551152us-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2021-06-300001551152srt:WeightedAverageMemberus-gaap:MeasurementInputDiscountRateMember2021-06-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MinimumMember2021-06-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:MaximumMember2021-06-300001551152abbv:ProbabilityofPaymentforUnachievedMilestonesMembersrt:WeightedAverageMember2021-06-300001551152abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMembersrt:MinimumMember2021-06-300001551152abbv:ProbabilityofPaymentforRoyaltiesbyIndicationMembersrt:MaximumMember2021-06-300001551152srt:WeightedAverageMemberabbv:ProbabilityofPaymentforRoyaltiesbyIndicationMember2021-06-300001551152abbv:ProjectedYearofPaymentsMembersrt:MinimumMember2021-06-300001551152abbv:ProjectedYearofPaymentsMembersrt:MaximumMember2021-06-300001551152srt:WeightedAverageMemberabbv:ProjectedYearofPaymentsMember2021-06-300001551152abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMembersrt:MinimumMember2021-06-300001551152abbv:ProbabilityofPaymentforRoyaltiesExcludingApprovedIndicationsMembersrt:MaximumMember2021-06-300001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-06-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-06-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-06-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-06-300001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-06-300001551152us-gaap:FairValueInputsLevel1Member2021-06-300001551152us-gaap:CarryingReportedAmountFairValueDisclosureMember2020-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMember2020-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2020-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-12-310001551152us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2020-12-310001551152us-gaap:FairValueInputsLevel1Member2020-12-31abbv:wholesaler0001551152us-gaap:AccountsReceivableMember2021-01-012021-06-300001551152us-gaap:GeographicConcentrationRiskMemberus-gaap:AccountsReceivableMemberabbv:PrincipalUSCustomersMember2021-01-012021-06-300001551152us-gaap:GeographicConcentrationRiskMemberus-gaap:AccountsReceivableMemberabbv:PrincipalUSCustomersMember2020-01-012020-12-310001551152us-gaap:SalesRevenueNetMemberabbv:HUMIRAMemberus-gaap:ProductConcentrationRiskMember2021-01-012021-06-300001551152us-gaap:SalesRevenueNetMemberabbv:HUMIRAMemberus-gaap:ProductConcentrationRiskMember2020-01-012020-06-300001551152us-gaap:SeniorNotesMemberabbv:SeniorNotes2.30PercentDue2021Member2021-04-012021-06-300001551152us-gaap:SeniorNotesMemberabbv:SeniorNotes2.30PercentDue2021Member2021-06-300001551152abbv:SeniorEuroNotesDue2021At0.500PercentMemberus-gaap:SeniorNotesMember2021-04-012021-06-300001551152abbv:SeniorEuroNotesDue2021At0.500PercentMemberus-gaap:SeniorNotesMember2021-06-300001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDueInMay2021AtFloatingRatesMember2021-05-012021-05-310001551152us-gaap:LoansPayableMemberabbv:May2020FloatingRateTermLoansMember2020-05-012020-05-310001551152abbv:July2019TermLoanCreditAgreementMemberus-gaap:LoansPayableMember2020-05-310001551152abbv:FloatingRateTermLoanTrancheDueMay2023Memberus-gaap:LoansPayableMember2020-06-300001551152us-gaap:LoansPayableMemberabbv:FloatingRateTermLoanTrancheDueMay2025Member2020-06-300001551152us-gaap:SeniorNotesMemberabbv:AllerganNotesExchangedMember2020-05-310001551152us-gaap:SeniorNotesMemberabbv:AllerganEuroNotesExchangedMember2020-05-310001551152us-gaap:SeniorNotesMemberabbv:AllerganNotesMember2020-05-310001551152abbv:AllerganEuroNotesMemberus-gaap:SeniorNotesMember2020-05-310001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDueIn2020At2.50PercentMember2020-05-012020-05-310001551152us-gaap:SeniorNotesMemberabbv:SeniorNotesDueIn2020At2.50PercentMember2020-05-310001551152us-gaap:CommercialPaperMember2020-12-310001551152us-gaap:CommercialPaperMember2021-06-300001551152us-gaap:CommercialPaperMember2020-06-300001551152us-gaap:PensionPlansDefinedBenefitMember2021-04-012021-06-300001551152us-gaap:PensionPlansDefinedBenefitMember2020-04-012020-06-300001551152us-gaap:PensionPlansDefinedBenefitMember2021-01-012021-06-300001551152us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-06-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-04-012021-06-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-04-012020-06-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2021-01-012021-06-300001551152us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-06-300001551152abbv:AbbVieAmendedAndRestated2013IncentiveStockProgramMember2021-05-012021-05-310001551152us-gaap:CostOfSalesMember2021-04-012021-06-300001551152us-gaap:CostOfSalesMember2020-04-012020-06-300001551152us-gaap:CostOfSalesMember2021-01-012021-06-300001551152us-gaap:CostOfSalesMember2020-01-012020-06-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2021-04-012021-06-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2020-04-012020-06-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-06-300001551152us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-06-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-04-012020-06-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001551152us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-06-300001551152us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001551152us-gaap:EmployeeStockOptionMember2021-06-300001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2021-01-012021-06-300001551152abbv:RestrictedStockUnitsAndPerformanceSharesMember2021-06-3000015511522021-06-172021-06-1700015511522020-10-302020-10-3000015511522021-02-182021-02-1800015511522020-09-112020-09-1100015511522020-06-172020-06-1700015511522020-02-202020-02-200001551152abbv:December2018StockRepurchaseAuthorizationMember2021-01-012021-06-300001551152abbv:December2018StockRepurchaseAuthorizationMember2020-01-012020-06-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2020-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2021-01-012021-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-06-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-01-012021-06-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2021-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-06-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2021-06-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2019-12-310001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2019-12-310001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2019-12-310001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-06-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2020-01-012020-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-06-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-01-012020-06-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-01-012020-06-300001551152us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-06-300001551152abbv:AccumulatedNetGainLossFromNetInvestmentHedgesMember2020-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-06-300001551152us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-06-300001551152us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember2020-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2021-04-012021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2020-04-012020-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2021-01-012021-06-300001551152us-gaap:NetInvestmentHedgingMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2020-01-012020-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2021-04-012021-06-300001551152us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2020-04-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeForwardMember2021-04-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeForwardMember2020-04-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeForwardMember2021-01-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeForwardMember2020-01-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-04-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-04-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:TreasuryLockMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-01-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:InterestRateSwapMember2021-04-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:InterestRateSwapMember2020-04-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:InterestRateSwapMember2021-01-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:InterestRateSwapMember2020-01-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-04-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-04-012020-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2021-01-012021-06-300001551152us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2020-01-012020-06-30abbv:lawsuit0001551152abbv:NiaspanMember2021-01-012021-06-30abbv:class_actionabbv:direct_purchaserabbv:end_payor_purchaserabbv:company0001551152abbv:AndroGelAntitrustLitigationMember2014-09-012014-09-300001551152abbv:DisgorgementRemedyMemberabbv:AndroGelAntitrustLitigationMember2018-06-012018-06-300001551152abbv:AndroGelAntitrustLitigationMember2020-09-012020-09-300001551152abbv:AndroGelAntitrustLitigationKingDrugCoOfFlorenceIncEtAlVAbbVieIncEtAlMember2019-08-012019-08-310001551152abbv:HumiraAntitrustLitigationInReHumiraAdalimumabAntitrustLitigationMember2019-03-012019-05-310001551152abbv:BystolicAntitrustLitigationMember2021-01-012021-06-30abbv:claim0001551152abbv:PrescriptionDrugAbuseLitigationMember2021-06-300001551152abbv:PrescriptionDrugAbuseLitigationInStateCourtsMember2021-06-30abbv:investment_fund0001551152abbv:ElliottAssociatesL.P.Member2016-06-012016-06-300001551152abbv:ElliottAssociatesL.P.Member2021-01-012021-06-300001551152abbv:ElliottAssociatesL.P.Member2020-06-300001551152abbv:GenericDrugPricingSecuritiesLitigationInU.S.DistrictCourtMember2021-01-012021-06-300001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2021-04-012021-06-300001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2020-04-012020-06-300001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2021-01-012021-06-300001551152abbv:HUMIRAMembercountry:USabbv:ImmunologyMember2020-01-012020-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMember2021-04-012021-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMember2020-04-012020-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMember2021-01-012021-06-300001551152abbv:HUMIRAMemberabbv:ImmunologyMember2020-01-012020-06-300001551152country:USabbv:ImmunologyMemberabbv:SKYRIZIMember2021-04-012021-06-300001551152country:USabbv:ImmunologyMemberabbv:SKYRIZIMember2020-04-012020-06-300001551152country:USabbv:ImmunologyMemberabbv:SKYRIZIMember2021-01-012021-06-300001551152country:USabbv:ImmunologyMemberabbv:SKYRIZIMember2020-01-012020-06-300001551152abbv:ImmunologyMemberus-gaap:NonUsMemberabbv:SKYRIZIMember2021-04-012021-06-300001551152abbv:ImmunologyMemberus-gaap:NonUsMemberabbv:SKYRIZIMember2020-04-012020-06-300001551152abbv:ImmunologyMemberus-gaap:NonUsMemberabbv:SKYRIZIMember2021-01-012021-06-300001551152abbv:ImmunologyMemberus-gaap:NonUsMemberabbv:SKYRIZIMember2020-01-012020-06-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2021-04-012021-06-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2020-04-012020-06-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2021-01-012021-06-300001551152abbv:ImmunologyMemberabbv:SKYRIZIMember2020-01-012020-06-300001551152country:USabbv:RINVOQMemberabbv:ImmunologyMember2021-04-012021-06-300001551152country:USabbv:RINVOQMemberabbv:ImmunologyMember2020-04-012020-06-300001551152country:USabbv:RINVOQMemberabbv:ImmunologyMember2021-01-012021-06-300001551152country:USabbv:RINVOQMemberabbv:ImmunologyMember2020-01-012020-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMember2021-04-012021-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMember2020-04-012020-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMember2021-01-012021-06-300001551152abbv:RINVOQMemberabbv:ImmunologyMember2020-01-012020-06-300001551152abbv:HematologicOncologyMembercountry:USabbv:ImbruvicaMember2021-04-012021-06-300001551152abbv:HematologicOncologyMembercountry:USabbv:ImbruvicaMember2020-04-012020-06-300001551152abbv:HematologicOncologyMembercountry:USabbv:ImbruvicaMember2021-01-012021-06-300001551152abbv:HematologicOncologyMembercountry:USabbv:ImbruvicaMember2020-01-012020-06-300001551152abbv:HematologicOncologyMemberus-gaap:NonUsMemberabbv:ImbruvicaMember2021-04-012021-06-300001551152abbv:HematologicOncologyMemberus-gaap:NonUsMemberabbv:ImbruvicaMember2020-04-012020-06-300001551152abbv:HematologicOncologyMemberus-gaap:NonUsMemberabbv:ImbruvicaMember2021-01-012021-06-300001551152abbv:HematologicOncologyMemberus-gaap:NonUsMemberabbv:ImbruvicaMember2020-01-012020-06-300001551152abbv:HematologicOncologyMemberabbv:ImbruvicaMember2021-04-012021-06-300001551152abbv:HematologicOncologyMemberabbv:ImbruvicaMember2020-04-012020-06-300001551152abbv:HematologicOncologyMemberabbv:ImbruvicaMember2021-01-012021-06-300001551152abbv:HematologicOncologyMemberabbv:ImbruvicaMember2020-01-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2021-04-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2020-04-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2021-01-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMembercountry:US2020-01-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2021-04-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2020-04-012020-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2021-01-012021-06-300001551152abbv:HematologicOncologyMemberabbv:VENCLEXTAMember2020-01-012020-06-300001551152abbv:AestheticsMembercountry:USabbv:BotoxCosmeticMember2021-04-012021-06-300001551152abbv:AestheticsMembercountry:USabbv:BotoxCosmeticMember2020-04-012020-06-300001551152abbv:AestheticsMembercountry:USabbv:BotoxCosmeticMember2021-01-012021-06-300001551152abbv:AestheticsMembercountry:USabbv:BotoxCosmeticMember2020-01-012020-06-300001551152abbv:AestheticsMemberus-gaap:NonUsMemberabbv:BotoxCosmeticMember2021-04-012021-06-300001551152abbv:AestheticsMemberus-gaap:NonUsMemberabbv:BotoxCosmeticMember2020-04-012020-06-300001551152abbv:AestheticsMemberus-gaap:NonUsMemberabbv:BotoxCosmeticMember2021-01-012021-06-300001551152abbv:AestheticsMemberus-gaap:NonUsMemberabbv:BotoxCosmeticMember2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:BotoxCosmeticMember2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMembercountry:US2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:JuvedermCollectionMember2020-01-012020-06-300001551152abbv:AestheticsMembercountry:USabbv:OtherAestheticsMember2021-04-012021-06-300001551152abbv:AestheticsMembercountry:USabbv:OtherAestheticsMember2020-04-012020-06-300001551152abbv:AestheticsMembercountry:USabbv:OtherAestheticsMember2021-01-012021-06-300001551152abbv:AestheticsMembercountry:USabbv:OtherAestheticsMember2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2021-04-012021-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2020-04-012020-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2021-01-012021-06-300001551152abbv:AestheticsMemberabbv:OtherAestheticsMember2020-01-012020-06-300001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2021-04-012021-06-300001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2020-04-012020-06-300001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2021-01-012021-06-300001551152abbv:BotoxTherapeuticMembercountry:USabbv:NeuroscienceMember2020-01-012020-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2021-04-012021-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2020-04-012020-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2021-01-012021-06-300001551152abbv:BotoxTherapeuticMemberabbv:NeuroscienceMember2020-01-012020-06-300001551152country:USabbv:NeuroscienceMemberabbv:VraylarMember2021-04-012021-06-300001551152country:USabbv:NeuroscienceMemberabbv:VraylarMember2020-04-012020-06-300001551152country:USabbv:NeuroscienceMemberabbv:VraylarMember2021-01-012021-06-300001551152country:USabbv:NeuroscienceMemberabbv:VraylarMember2020-01-012020-06-300001551152country:USabbv:DuodopaMemberabbv:NeuroscienceMember2021-04-012021-06-300001551152country:USabbv:DuodopaMemberabbv:NeuroscienceMember2020-04-012020-06-300001551152country:USabbv:DuodopaMemberabbv:NeuroscienceMember2021-01-012021-06-300001551152country:USabbv:DuodopaMemberabbv:NeuroscienceMember2020-01-012020-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2021-04-012021-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2020-04-012020-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2021-01-012021-06-300001551152abbv:DuodopaMemberabbv:NeuroscienceMember2020-01-012020-06-300001551152country:USabbv:NeuroscienceMemberabbv:UbrelvyMember2021-04-012021-06-300001551152country:USabbv:NeuroscienceMemberabbv:UbrelvyMember2020-04-012020-06-300001551152country:USabbv:NeuroscienceMemberabbv:UbrelvyMember2021-01-012021-06-300001551152country:USabbv:NeuroscienceMemberabbv:UbrelvyMember2020-01-012020-06-300001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2021-04-012021-06-300001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2020-04-012020-06-300001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2021-01-012021-06-300001551152abbv:OtherNeuroscienceMembercountry:USabbv:NeuroscienceMember2020-01-012020-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMember2021-04-012021-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMember2020-04-012020-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMember2021-01-012021-06-300001551152abbv:OtherNeuroscienceMemberabbv:NeuroscienceMember2020-01-012020-06-300001551152country:USabbv:EyeCareMemberabbv:LumiganGanfortMember2021-04-012021-06-300001551152country:USabbv:EyeCareMemberabbv:LumiganGanfortMember2020-04-012020-06-300001551152country:USabbv:EyeCareMemberabbv:LumiganGanfortMember2021-01-012021-06-300001551152country:USabbv:EyeCareMemberabbv:LumiganGanfortMember2020-01-012020-06-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:LumiganGanfortMember2021-04-012021-06-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:LumiganGanfortMember2020-04-012020-06-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:LumiganGanfortMember2021-01-012021-06-300001551152abbv:EyeCareMemberus-gaap:NonUsMemberabbv:LumiganGanfortMember2020-01-012020-06-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2021-04-012021-06-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2020-04-012020-06-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2021-01-012021-06-300001551152abbv:EyeCareMemberabbv:LumiganGanfortMember2020-01-012020-06-300001551152country:USabbv:AlphaganCombiganMemberabbv:EyeCareMember2021-04-012021-06-300001551152country:USabbv:AlphaganCombiganMemberabbv:EyeCareMember2020-04-012020-06-300001551152country:USabbv:AlphaganCombiganMemberabbv:EyeCareMember2021-01-012021-06-300001551152country:USabbv:AlphaganCombiganMemberabbv:EyeCareMember2020-01-012020-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2021-04-012021-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2020-04-012020-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2021-01-012021-06-300001551152abbv:AlphaganCombiganMemberabbv:EyeCareMember2020-01-012020-06-300001551152abbv:RestasisMembercountry:USabbv:EyeCareMember2021-04-012021-06-300001551152abbv:RestasisMembercountry:USabbv:EyeCareMember2020-04-012020-06-300001551152abbv:RestasisMembercountry:USabbv:EyeCareMember2021-01-012021-06-300001551152abbv:RestasisMembercountry:USabbv:EyeCareMember2020-01-012020-06-300001551152abbv:RestasisMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:RestasisMemberabbv:EyeCareMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:RestasisMemberabbv:EyeCareMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:RestasisMemberabbv:EyeCareMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:RestasisMemberabbv:EyeCareMember2021-04-012021-06-300001551152abbv:RestasisMemberabbv:EyeCareMember2020-04-012020-06-300001551152abbv:RestasisMemberabbv:EyeCareMember2021-01-012021-06-300001551152abbv:RestasisMemberabbv:EyeCareMember2020-01-012020-06-300001551152country:USabbv:EyeCareMemberabbv:OtherEyeCareMember2021-04-012021-06-300001551152country:USabbv:EyeCareMemberabbv:OtherEyeCareMember2020-04-012020-06-300001551152country:USabbv:EyeCareMemberabbv:OtherEyeCareMember2021-01-012021-06-300001551152country:USabbv:EyeCareMemberabbv:OtherEyeCareMember2020-01-012020-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMember2021-04-012021-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMember2020-04-012020-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMember2021-01-012021-06-300001551152abbv:EyeCareMemberabbv:OtherEyeCareMember2020-01-012020-06-300001551152abbv:LoLoestrinMembercountry:USabbv:WomensHealthMember2021-04-012021-06-300001551152abbv:LoLoestrinMembercountry:USabbv:WomensHealthMember2020-04-012020-06-300001551152abbv:LoLoestrinMembercountry:USabbv:WomensHealthMember2021-01-012021-06-300001551152abbv:LoLoestrinMembercountry:USabbv:WomensHealthMember2020-01-012020-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMember2021-04-012021-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMember2020-04-012020-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMember2021-01-012021-06-300001551152abbv:LoLoestrinMemberabbv:WomensHealthMember2020-01-012020-06-300001551152country:USabbv:OrilissaOriahnnMemberabbv:WomensHealthMember2021-04-012021-06-300001551152country:USabbv:OrilissaOriahnnMemberabbv:WomensHealthMember2020-04-012020-06-300001551152country:USabbv:OrilissaOriahnnMemberabbv:WomensHealthMember2021-01-012021-06-300001551152country:USabbv:OrilissaOriahnnMemberabbv:WomensHealthMember2020-01-012020-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMember2021-04-012021-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMember2020-04-012020-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMember2021-01-012021-06-300001551152abbv:OrilissaOriahnnMemberabbv:WomensHealthMember2020-01-012020-06-300001551152country:USabbv:WomensHealthMemberabbv:OtherWomensHealthMember2021-04-012021-06-300001551152country:USabbv:WomensHealthMemberabbv:OtherWomensHealthMember2020-04-012020-06-300001551152country:USabbv:WomensHealthMemberabbv:OtherWomensHealthMember2021-01-012021-06-300001551152country:USabbv:WomensHealthMemberabbv:OtherWomensHealthMember2020-01-012020-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMember2021-04-012021-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMember2020-04-012020-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMember2021-01-012021-06-300001551152abbv:WomensHealthMemberabbv:OtherWomensHealthMember2020-01-012020-06-300001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:MAVYRETMembercountry:USabbv:OtherKeyProductsMember2020-01-012020-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:MAVYRETMemberabbv:OtherKeyProductsMember2020-01-012020-06-300001551152country:USabbv:CreonMemberabbv:OtherKeyProductsMember2021-04-012021-06-300001551152country:USabbv:CreonMemberabbv:OtherKeyProductsMember2020-04-012020-06-300001551152country:USabbv:CreonMemberabbv:OtherKeyProductsMember2021-01-012021-06-300001551152country:USabbv:CreonMemberabbv:OtherKeyProductsMember2020-01-012020-06-300001551152abbv:LupronMembercountry:USabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:LupronMembercountry:USabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:LupronMembercountry:USabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:LupronMembercountry:USabbv:OtherKeyProductsMember2020-01-012020-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:LupronMemberabbv:OtherKeyProductsMember2020-01-012020-06-300001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:LinzessConstellaMembercountry:USabbv:OtherKeyProductsMember2020-01-012020-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-04-012021-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-04-012020-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2021-01-012021-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMemberus-gaap:NonUsMember2020-01-012020-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMember2021-04-012021-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMember2020-04-012020-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMember2021-01-012021-06-300001551152abbv:LinzessConstellaMemberabbv:OtherKeyProductsMember2020-01-012020-06-300001551152country:USabbv:OtherKeyProductsMemberabbv:SynthroidMember2021-04-012021-06-300001551152country:USabbv:OtherKeyProductsMemberabbv:SynthroidMember2020-04-012020-06-300001551152country:USabbv:OtherKeyProductsMemberabbv:SynthroidMember2021-01-012021-06-300001551152country:USabbv:OtherKeyProductsMemberabbv:SynthroidMember2020-01-012020-06-300001551152abbv:OtherProductsMember2021-04-012021-06-300001551152abbv:OtherProductsMember2020-04-012020-06-300001551152abbv:OtherProductsMember2021-01-012021-06-300001551152abbv:OtherProductsMember2020-01-012020-06-30abbv:segment

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
OR
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                                    to                                   
Commission File Number: 001-35565
abbv-20210630_g1.jpg
AbbVie Inc.
(Exact name of registrant as specified in its charter)
Delaware
32-0375147
(State or other jurisdiction of incorporation or organization)
(I.R.S. employer identification number)
1 North Waukegan Road
North ChicagoIllinois 60064-6400
Telephone: (847) 932-7900
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.        Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
Accelerated Filer
Non-Accelerated FilerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).        Yes No
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareABBVNew York Stock Exchange
Chicago Stock Exchange
1.500% Senior Notes due 2023ABBV23BNew York Stock Exchange
1.375% Senior Notes due 2024ABBV24New York Stock Exchange
1.250% Senior Notes due 2024ABBV24BNew York Stock Exchange
0.750% Senior Notes due 2027ABBV27New York Stock Exchange
2.125% Senior Notes due 2028ABBV28New York Stock Exchange
2.625% Senior Notes due 2028ABBV28BNew York Stock Exchange
2.125% Senior Notes due 2029ABBV29New York Stock Exchange
1.250% Senior Notes due 2031ABBV31New York Stock Exchange
As of July 26, 2021, AbbVie Inc. had 1,767,175,532 shares of common stock at $0.01 par value outstanding.



AbbVie Inc. and Subsidiaries
Table of Contents

Page




PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings (unaudited)

Three months ended
June 30,
Six months ended
June 30,
(in millions, except per share data)2021202020212020
Net revenues$13,959 $10,425 $26,969 $19,044 
Cost of products sold4,523 3,711 8,736 5,653 
Selling, general and administrative3,164 3,527 6,006 5,222 
Research and development1,802 1,582 3,584 2,961 
Acquired in-process research and development97 853 167 853 
Other operating income(68) (68) 
Total operating costs and expenses9,518 9,673 18,425 14,689 
Operating earnings4,441 752 8,544 4,355 
Interest expense, net606 614 1,228 1,042 
Net foreign exchange loss14 29 23 34 
Other expense, net2,658 802 2,263 874 
Earnings (loss) before income tax expense1,163 (693)5,030 2,405 
Income tax expense394 46 706 134 
Net earnings (loss)769 (739)4,324 2,271 
Net earnings (loss) attributable to noncontrolling interest3 (1)5 (1)
Net earnings (loss) attributable to AbbVie Inc.$766 $(738)$4,319 $2,272 
Per share data
Basic earnings (loss) per share attributable to AbbVie Inc.$0.42 $(0.46)$2.42 $1.44 
Diluted earnings (loss) per share attributable to AbbVie Inc.$0.42 $(0.46)$2.41 $1.43 
Weighted-average basic shares outstanding1,769 1,647 1,769 1,564 
Weighted-average diluted shares outstanding1,776 1,647 1,776 1,568 

The accompanying notes are an integral part of these condensed consolidated financial statements.
2021 Form 10-Q | abbv-20210630_g2.gif
1


AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (unaudited)

Three months ended
June 30,
Six months ended
June 30,
(in millions)2021202020212020
Net earnings (loss)$769 $(739)$4,324 $2,271 
Foreign currency translation adjustments, net of tax expense (benefit) of $1 for the three months and $(24) for the six months ended June 30, 2021 and $4 for the three months and $(4) for the six months ended June 30, 2020
244 441 (433)214 
Net investment hedging activities, net of tax expense (benefit) of $(31) for the three months and $72 for the six months ended June 30, 2021 and $(60) for the three months and $(40) for the six months ended June 30, 2020
(114)(213)260 (141)
Pension and post-employment benefits, net of tax expense (benefit) of $14 for the three months and $33 for the six months ended June 30, 2021 and $12 for the three months and $27 for six months ended June 30, 2020
50 43 129 99 
Cash flow hedging activities, net of tax expense (benefit) of $ for the three months and $3 for the six months ended June 30, 2021 and $(2) for the three months and $(4) for the six months ended June 30, 2020
12 (9)58 (11)
Other comprehensive income192 262 14 161 
Comprehensive income (loss)961 (477)4,338 2,432 
Comprehensive income (loss) attributable to noncontrolling interest3 (1)5 (1)
Comprehensive income (loss) attributable to AbbVie Inc.$958 $(476)$4,333 $2,433 

The accompanying notes are an integral part of these condensed consolidated financial statements.




2021 Form 10-Q | abbv-20210630_g2.gif
2


AbbVie Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in millions, except share data)June 30,
2021
December 31, 2020
(unaudited)
Assets
Current assets
Cash and equivalents$8,546 $8,449 
Short-term investments54 30 
Accounts receivable, net9,914 8,822 
Inventories3,386 3,310 
Prepaid expenses and other4,099 3,562 
Total current assets25,999 24,173 
Investments266 293 
Property and equipment, net5,161 5,248 
Intangible assets, net79,340 82,876 
Goodwill32,398 33,124 
Other assets4,808 4,851 
Total assets$147,972 $150,565 
Liabilities and Equity
Current liabilities
Short-term borrowings$17 $34 
Current portion of long-term debt and finance lease obligations7,884 8,468 
Accounts payable and accrued liabilities20,783 20,159 
Total current liabilities28,684 28,661 
Long-term debt and finance lease obligations74,237 77,554 
Deferred income taxes3,661 3,646 
Other long-term liabilities28,796 27,607 
Commitments and contingencies
Stockholders' equity
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,801,041,492 shares issued as of June 30, 2021 and 1,792,140,764 as of December 31, 2020
18 18 
Common stock held in treasury, at cost, 34,015,942 shares as of June 30, 2021 and 27,007,945 as of December 31, 2020
(3,022)(2,264)
Additional paid-in capital17,936 17,384 
Retained earnings740 1,055 
Accumulated other comprehensive loss(3,103)(3,117)
Total stockholders' equity12,569 13,076 
Noncontrolling interest25 21 
Total equity12,594 13,097 
Total liabilities and equity$147,972 $150,565 
The accompanying notes are an integral part of these condensed consolidated financial statements.
2021 Form 10-Q | abbv-20210630_g2.gif
3


AbbVie Inc. and Subsidiaries
Condensed Consolidated Statements of Equity (unaudited)

(in millions)Common shares outstandingCommon stockTreasury stockAdditional paid-in capitalRetained earningsAccumulated other comprehensive lossNoncontrolling interestTotal
Balance at March 31, 20201,477 $18 $(25,110)$15,401 $5,973 $(3,697)$ $(7,415)
Net loss attributable to AbbVie Inc.—    (738)  (738)
Other comprehensive income, net of tax—     262  262 
Dividends declared—    (2,105)  (2,105)
Common shares and equity awards issued for acquisition of Allergan plc
286  23,166 1,243    24,409 
Purchases of treasury stock  (19)    (19)
Stock-based compensation plans and other1  5 309    314 
Change in noncontrolling interest—      24 24 
Balance at June 30, 20201,764 $18 $(1,958)$16,953 $3,130 $(3,435)$24 $14,732 
Balance at March 31, 20211,766 $18 $(3,017)$17,712 $2,292 $(3,295)$23 $13,733 
Net earnings attributable to AbbVie Inc.—    766   766 
Other comprehensive income, net of tax—     192  192 
Dividends declared—    (2,318)  (2,318)
Purchases of treasury stock  (10)    (10)
Stock-based compensation plans and other1  5 224    229 
Change in noncontrolling interest—      2 2 
Balance at June 30, 20211,767 $18 $(3,022)$17,936 $740 $(3,103)$25 $12,594 
Balance at December 31, 20191,479 $18 $(24,504)$15,193 $4,717 $(3,596)$ $(8,172)
Net earnings attributable to AbbVie Inc.—    2,272   2,272 
Other comprehensive income, net of tax—     161  161 
Dividends declared—    (3,859)  (3,859)
Common shares and equity awards issued for acquisition of Allergan plc
286  23,166 1,243    24,409 
Purchases of treasury stock(7) (662)    (662)
Stock-based compensation plans and other6  42 517    559 
Change in noncontrolling interest—      24 24 
Balance at June 30, 20201,764 $18 $(1,958)$16,953 $3,130 $(3,435)$24 $14,732 
Balance at December 31, 20201,765 $18 $(2,264)$17,384 $1,055 $(3,117)$21 $13,097 
Net earnings attributable to AbbVie Inc.—    4,319   4,319 
Other comprehensive income, net of tax—     14  14 
Dividends declared—    (4,634)  (4,634)
Purchases of treasury stock(7) (797)    (797)
Stock-based compensation plans and other9  39